In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Plus Therapeutics (PSTV – Research Report), with a ...

Analyst Divya Gangahar from Morgan Stanley maintained a Buy rating on Grab (GRAB – Research Report) and increased the price target to ...

Read here for an update on Tesla's upcoming catalysts in Oct., including the robotaxi event and Q3 release, and TSLA's ...

Looking to buy ASX shares with strong growth potential? Here are three Aussie stocks brokers just upgraded to buys and one to ...

Toll Brothers (TOL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...

Brokers are tipping these shares to rise strongly from current levels. The post Got $3,000? Buy these ASX shares in October ...

On Tuesday, Denali Therapeutics Inc (DNLI) stock saw a decline, ending the day at $28.67 which represents a decrease of $-0.46 or -1.58% from the prior close of $29.13. The stock opened at $29.18 and ...

Tesla is expected to unveil its autonomous "robotaxi" on Oct. 10, with analysts expecting details about the new vehicle and other potential announcements like a lower-cost model or updates to its ...

On Tuesday, Kilroy Realty Corp (KRC) stock saw a decline, ending the day at $38.27 which represents a decrease of $-0.43 or -1.11% from the prior close of $38.7. The stock opened at $38.58 and touched ...

More than 530,000 Long Islanders live in properties at serious risk of flooding, according to new estimates published ...

Historically, FactSet’s adjusted operating margins have been range-bound in the low to mid-30s. However, as the firm increases scale it has recently pushed margins into the 37% to 38% range.

Compact and small cars may not be as popular as SUVs, but they still serve a purpose well for many of us, here are 2024's 10 ...